SXTP (60 Degrees Pharmaceuticals, Inc.) Short-Term Debt to Capital

The historical price action of 60 Degrees Pharmaceuticals (SXTP) on the GURU.Markets platform, where the indicator stands at 0.00, demonstrates the business's independence from global economic cycles, relying instead on the success of clinical trials and drug sales. 60 Degrees Pharmaceuticals focuses on protecting military personnel and tourists by launching certified treatments for tropical diseases. Revenue is generated through the sale of Arakoda and the development of therapies for respiratory viruses.

This ratio determines the share of short-term loans within the equity structure, where analyzing the trend of short-term liabilities to equity allows for an assessment of liquidity and default risk; for 60 Degrees Pharmaceuticals (SXTP), this balance is critical, as the stability of the Aravacon patent perimeter and long-term B2B contracts with clinics must ensure the coverage of current debts without diluting shareholder value.